Development of Next Generation Purification Platforms through Novel Technologies and Holistic Process Engineering Approaches Originally delivered May 2, 2018 Source: 3M | This webinar is sponsored by 3M and reflects their views, opinions, and insights. Attendance is free. Type: Archived WebinarLevel: Advanced Duration: 1 hour PDHs: 0.00 Share This Post: Preview Webinar: How can you address new requirements to shrink time to clinic and decrease biopharmaceutical manufacturing cost and risk? Take this webinar to find out. Join 3M’s, Alexei Voloshin, as he discusses process intensification of mAb manufacturing using novel chemistries to drive efficiency and economics. In this 60-minute sponsored webinar, you’ll be introduced to new technologies and approaches to meet manufacturers’ existing process challenges and expected rise in market demand. You’ll learn how to address purification challenges by reducing both particulates and soluble contaminants at the end of the primary clarification stage of mammalian cell cultures. Through this webinar, you’ll see how new technology produces process impurity and viral clearance performance that are qualitatively higher than today’s approaches. Could much simpler and more robust purification process strategies address the emerging challenges in your future? Find out here. Take a look at your agenda: Integrating new technology with existing manufacturing processes Significant cost savings and other benefits Applying new technology to a wide range of applications Examples of how new strategies for mAb purification are enabled Presenter(s): Alexei Voloshin Alexei Voloshin is the Global Application Strategy Specialist at 3M Separation and Purification Sciences Division. He is responsible for product application strategy and manages technology projects, collaborations, and alliances around the globe. Alexei brings more than 15 years of experience in bio-process development, as well as technical, operational, and business knowledge in the biotechnology space. Before joining 3M, Alexei led molecular diagnostics program at Theranos Inc. He is also a founding member of TheraOne Inc., a start-up company focused on front line cancer...Read more Checkout Checkout Do you already own this? Log In for instructions on accessing this content. Pricing Individuals AIChE Members Free AIChE Graduate Student Members Free AIChE Undergraduate Student Members Free Non-Members $0.00 Sponsored webinars bring technical information from reputable firms and suppliers to AIChE members. The content reflects the views, opinions, and recommendations of the sponsoring organization. AIChE does not warrant or represent, expressly or by implication, the correctness or accuracy of the content of the information presented. As between (1) the AIChE, the presenter and author(s) of this work, their employers, and their employers' officers and directors, and (2) the user/viewer of this work, the user/viewer accepts any legal liability or responsibility whatsoever for the consequence of its use or misuse. Contact information for attendees of this webinar, including email address, will be shared with the sponsoring firm. You will always have the opportunity to unsubscribe from email from that organization. Language: English
Alexei Voloshin Alexei Voloshin is the Global Application Strategy Specialist at 3M Separation and Purification Sciences Division. He is responsible for product application strategy and manages technology projects, collaborations, and alliances around the globe. Alexei brings more than 15 years of experience in bio-process development, as well as technical, operational, and business knowledge in the biotechnology space. Before joining 3M, Alexei led molecular diagnostics program at Theranos Inc. He is also a founding member of TheraOne Inc., a start-up company focused on front line cancer...Read more